questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Vascularite
Vascularite : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic and Statistical Manual of Mental Disorders
Diagnostic
5
Vascularite
Biopsie
Imagerie médicale
Tests sanguins
Inflammation
Vitesse de sédimentation
Symptômes
Fatigue
Éruption cutanée
Biopsie
Diagnostic
Vascularite
Rhumatologie
Médecine interne
Vascularite
Symptômes
5
Symptômes
Fatigue
Éruption cutanée
Douleurs articulaires
Vascularite
Symptômes
Symptômes neurologiques
Vascularite
Engourdissement
Éruption cutanée
Purpura
Vascularite
Organes internes
Complications
Vascularite
Prévention
5
Prévention
Suivi médical
Vascularite
Vaccination
Prévention
Infections
Déclencheurs
Prévention
Vascularite
Suivi médical
Vascularite
Traitement
Alimentation
Antioxydants
Vascularite
Traitements
5
Corticostéroïdes
Immunosuppresseurs
Traitement
Corticostéroïdes
Inflammation
Vascularite
Immunosuppresseurs
Vascularite
Traitement
Thérapies biologiques
Vascularite
Traitement
Traitement
Vascularite
Suivi médical
Complications
5
Complications
Lésions organiques
Vascularite
Insuffisance rénale
Complications
Vascularite
Risques cardiovasculaires
AVC
Vascularite
Complications
Traitement
Vascularite
Surveillance
Examens médicaux
Vascularite
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Vascularite
Âge
Facteurs de risque
Vascularite
Infections
Déclencheurs
Vascularite
Tabagisme
Facteurs de risque
Vascularite
Maladies auto-immunes
Facteurs de risque
Vascularite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vascularite : Questions médicales les plus fréquentes",
"headline": "Vascularite : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vascularite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vascularite"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies vasculaires",
"url": "https://questionsmedicales.fr/mesh/D014652",
"about": {
"@type": "MedicalCondition",
"name": "Maladies vasculaires",
"code": {
"@type": "MedicalCode",
"code": "D014652",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aortite",
"alternateName": "Aortitis",
"url": "https://questionsmedicales.fr/mesh/D001025",
"about": {
"@type": "MedicalCondition",
"name": "Aortite",
"code": {
"@type": "MedicalCode",
"code": "D001025",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Artérite",
"alternateName": "Arteritis",
"url": "https://questionsmedicales.fr/mesh/D001167",
"about": {
"@type": "MedicalCondition",
"name": "Artérite",
"code": {
"@type": "MedicalCode",
"code": "D001167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Endartérite",
"alternateName": "Endarteritis",
"url": "https://questionsmedicales.fr/mesh/D004692",
"about": {
"@type": "MedicalCondition",
"name": "Endartérite",
"code": {
"@type": "MedicalCode",
"code": "D004692",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090.340"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Cogan",
"alternateName": "Cogan Syndrome",
"url": "https://questionsmedicales.fr/mesh/D055952",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Cogan",
"code": {
"@type": "MedicalCode",
"code": "D055952",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phlébite",
"alternateName": "Phlebitis",
"url": "https://questionsmedicales.fr/mesh/D010689",
"about": {
"@type": "MedicalCondition",
"name": "Phlébite",
"code": {
"@type": "MedicalCode",
"code": "D010689",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thrombophlébite",
"alternateName": "Thrombophlebitis",
"url": "https://questionsmedicales.fr/mesh/D013924",
"about": {
"@type": "MedicalCondition",
"name": "Thrombophlébite",
"code": {
"@type": "MedicalCode",
"code": "D013924",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vascularite rétinienne",
"alternateName": "Retinal Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D031300",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite rétinienne",
"code": {
"@type": "MedicalCode",
"code": "D031300",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.815"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vascularite systémique",
"alternateName": "Systemic Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D056647",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite systémique",
"code": {
"@type": "MedicalCode",
"code": "D056647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.897"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thromboangéite oblitérante",
"alternateName": "Thromboangiitis Obliterans",
"url": "https://questionsmedicales.fr/mesh/D013919",
"about": {
"@type": "MedicalCondition",
"name": "Thromboangéite oblitérante",
"code": {
"@type": "MedicalCode",
"code": "D013919",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.905"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vascularite",
"alternateName": "Vasculitis",
"code": {
"@type": "MedicalCode",
"code": "D014657",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David S Younger",
"url": "https://questionsmedicales.fr/author/David%20S%20Younger",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu."
}
},
{
"@type": "Person",
"name": "Tanaz A Kermani",
"url": "https://questionsmedicales.fr/author/Tanaz%20A%20Kermani",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Christian Pagnoux",
"url": "https://questionsmedicales.fr/author/Christian%20Pagnoux",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto."
}
},
{
"@type": "Person",
"name": "Cristina Ponte",
"url": "https://questionsmedicales.fr/author/Cristina%20Ponte",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com."
}
},
{
"@type": "Person",
"name": "Nikita Khmelinskii",
"url": "https://questionsmedicales.fr/author/Nikita%20Khmelinskii",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Validity of the revised Diagnostic and Statistical Manual of Mental Disorders-5 cross-cutting symptom measure as implemented in community mental health settings.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37844781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.10.077"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interrater reliability of criterion A of the alternative model for personality disorder (Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition-Section III): A meta-analysis.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227864",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/31803"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychopathy and antisocial personality disorder in the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders: An attempted replication of Wygant et al. (2016).",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227862",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000626"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional impairment, insight, and comparison between criteria for gaming disorder in the International Classification of Diseases, 11 Edition and internet gaming disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36326855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00079"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vascularite",
"item": "https://questionsmedicales.fr/mesh/D014657"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vascularite - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vascularite",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vascularite",
"description": "Comment diagnostiquer une vascularite ?\nQuels tests sanguins sont utilisés ?\nQuels symptômes indiquent une vascularite ?\nLa biopsie est-elle toujours nécessaire ?\nQuels spécialistes consultent pour une vascularite ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vascularite",
"description": "Quels sont les symptômes courants de la vascularite ?\nLa vascularite peut-elle causer des douleurs articulaires ?\nY a-t-il des symptômes neurologiques associés ?\nLes éruptions cutanées sont-elles spécifiques ?\nLa vascularite peut-elle affecter les organes internes ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vascularite",
"description": "Peut-on prévenir la vascularite ?\nLes vaccinations sont-elles recommandées ?\nComment éviter les déclencheurs ?\nLe suivi médical est-il important ?\nY a-t-il des conseils diététiques ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vascularite",
"description": "Quels traitements sont disponibles pour la vascularite ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des immunosuppresseurs ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vascularite",
"description": "Quelles sont les complications possibles de la vascularite ?\nLa vascularite peut-elle entraîner des problèmes rénaux ?\nQuels risques cardiovasculaires sont associés ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vascularite",
"description": "Quels sont les facteurs de risque de la vascularite ?\nL'âge influence-t-il le risque de vascularite ?\nLes infections peuvent-elles déclencher une vascularite ?\nLe tabagisme est-il un facteur de risque ?\nCertaines maladies auto-immunes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une vascularite ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une vascularite ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle toujours nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants."
}
},
{
"@type": "Question",
"name": "Quels spécialistes consultent pour une vascularite ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la vascularite ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle causer des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs articulaires sont fréquentes et peuvent être sévères."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle affecter les organes internes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la vascularite ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite."
}
},
{
"@type": "Question",
"name": "Comment éviter les déclencheurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, le stress et les infections peut réduire les risques de poussées."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la vascularite ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement."
}
},
{
"@type": "Question",
"name": "Quand utilise-t-on des immunosuppresseurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la vascularite ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle entraîner des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer une insuffisance rénale aiguë ou chronique."
}
},
{
"@type": "Question",
"name": "Quels risques cardiovasculaires sont associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de fonction organique sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la vascularite ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de vascularite ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher une vascularite ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections virales ou bactériennes peuvent être des déclencheurs."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de vascularite."
}
},
{
"@type": "Question",
"name": "Certaines maladies auto-immunes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu.
Publications dans "Vascularite" :
3 publications dans cette catégorie
Affiliations :
Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA.
Publications dans "Vascularite" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, Leeds, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: e.brouwer@umcg.nl.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Division of Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Hacettepe University Vasculitis Research Center, Ankara, Turkey.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Rheumatology and Division of Clinical Epidemiology, University of Pennsylvania, Philadelphia, PA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Musgrove Park Hospital, Taunton, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK matthew.wells@nbt.nhs.uk.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
North Bristol Trust, Bristol, UK.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic, Phoenix, Arizona, USA.
Publications dans "Vascularite" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Publications dans "Vascularite" :
The purpose of this study was to validate the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Cross-Cutting Symptom Measure (CCSM) as a screening tool for a wide variety of disorders w...
Participants (N = 851) were referred for coordinated specialty care services (mean age = 20.26 years (SD = 2.97); 82.5 % Caucasian, 7.5 % African American, 0.7 % Native American, 0.7 % Pacific Islande...
At optimal cut-score, specificity ranged from 57 to 77 % for depression, anxiety, substance use and psychosis domains; sensitivity ranged from 63 to 72 %. Scores for depression, anxiety, substance use...
Criterion measures did not have inter-rater reliabilities as this is generally prohibitive in clinic settings....
The CCSM could provide a first step in screening for multiple disorders; however, it cannot replace structured interviews for making diagnoses related to these conditions....
The alternative model for personality disorder (AMPD) is currently included in Section III of the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5). This review sought to s...
Screen use is part of daily life worldwide and morbidity related to excess use of screens has been reported. Some use of screens in excess could indicate a screen use disorder (ScUD). An integrative a...
Our goals were (1) to describe screen uses in a general population sample and (2) to test the unidimensionality, local independence, and psychometric properties of the 9 Diagnostic and Statistical Man...
This cross-sectional survey in a French suburban city targeted adults and adolescents. A self-administered questionnaire covered the main types of screens used and their use for various activities in ...
Among the 300 participants, 171 (57.0%) were female (mean age 27 years), 297 (99.0%) used screens, 134 (44.7%) reported at least one criterion (potential problem users), and 5 (1.7%) reported 5 or mor...
We described screen uses in a French community sample and have shown that the adaptation of the DSM-5 IGD to "ScUD" has good psychometric validity and is discriminating, confirming our hypothesis. We ...
The fifth edition of the American Psychiatric Association's (APA)...
This study evaluated the consistency between the International Classification of Diseases, 11th Edition (ICD-11) for gaming disorder (ICD-11-GD) and Diagnostic and Statistical Manual of Mental Disorde...
We recruited 60 participants with GD, 45 participants who engaged in hazardous gaming (HG), and 120 controls based on a diagnostic interview. Their operationalization of functional impairment and stag...
We observed satisfactory consistency (kappa value = 0.80) with a diagnostic accuracy of 91.5% between the ICD-11-GD and DSM-5-IGD criteria. Furthermore, 16 participants with IGD in DSM-5 were determin...
There is a good consistency between ICD-11-GD and DSM-5-IGD criteria. The ICD-11 criteria have a high threshold for diagnosing GD. HG criteria could compensate for this high threshold and identify ind...
The conceptual basis of psychopathology within cancer survivorship is critical, as the chosen conceptualisation informs assessment and explanatory models, as well as interventions and supportive care ...
Age-related psychometric differences in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) opioid use disorder (OUD) diagnostic criteria have been hypothesized, but not been te...
People who participated in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III and reported past 12-month nonmedical use of prescription opioids were included. YAs were 1...
One in 5 people met the DSM-5 OUD diagnostic criteria for OUD within the past 12 months, with the most endorsed criteria being tolerance (17.96%). DIF was identified for 3 criteria, including (1) taki...
These findings suggest that there may be age-related variations in the DSM-5 OUD diagnostic criteria's ability to detect latent OUD. Future research should identify contributing factors and the influe...
There is a scarcity of summarizing data on the epidemiology of insomnia in older persons, especially when diagnosed with international criteria. This study aimed to estimate the prevalence and correla...
Through PubMed/MEDLINE, EMBASE, and Web of Science (WoS), we searched for relevant articles published before June 28, 2023. The risk of bias was weighed using the Joanna Briggs Institute's (JBI's) cri...
We included 18,270 participants across 16 studies. The male/female ratio was 0.89 (12 studies), and the mean age varied from 65.9 to 83.1 years (8 studies). The pooled prevalence of insomnia was 19.6%...
Nearly one in every five old individuals was considered to have insomnia disorder, which was associated with the gender and the existence of mental health and/or somatic conditions....
We registered the protocol in the International Prospective Register of Systematic Reviews (PROSPERO) with registration number: CRD42022344675....
The alternative model of personality disorders (AMPD) traits were designed to maintain continuity with the Section II personality disorder (PD) diagnoses by retaining the same clinical information. Wh...
The Impact of Event Scale-Revised (IES-R) is a widely used self-report for assessing posttraumatic stress disorder (PTSD), originally aligned with Diagnostic and Statistical Manual of Mental Disorders...
A total of 238 participants recruited from multiple psychiatric centers, including 67 patients with PTSD, 72 patients with psychiatric controls, and 99 healthy controls, were included in the study. Al...
The IES-R demonstrated good internal consistency and a high correlation with the PCL-5. Through factor analysis, 5 distinct dimensions emerged within the IES-R: sleep disturbance, intrusion, hyperarou...
These findings underscore the scale's concurrent validity with the DSM-5 PTSD criteria and its effectiveness as a screening tool. Implementing a cutoff score of 25 on the IES-R can enhance its utility...